High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia. 1989

D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
Department of Medicine, University Hospital Rebro, Zagreb, Yugoslavia.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
March 1997, Blood reviews,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
July 1982, British journal of haematology,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
February 1986, Scandinavian journal of haematology,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
October 1992, European journal of haematology,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
August 1982, Scandinavian journal of haematology,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
August 1988, Cancer,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
January 1987, Haematology and blood transfusion,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
September 1990, British journal of cancer,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
August 1987, Klinische Wochenschrift,
D Nemet, and B Labar, and V Bogdanić, and E Hauptman, and B Jaksić, and H Minigo, and D Sertić, and M Mrsić, and Z Pavletić, and J Kovacević
March 1985, Scandinavian journal of haematology,
Copied contents to your clipboard!